Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial.
Michael A PfefferTia C L KohsHelen H VuKelley R JordanSi-Han WangChristina U LorentzErik I TuckerCristina PuySven R OlsonThomas G DeLougheryMonica T HindsRavi S KeshariDavid GailaniFlorea LupuOwen J T McCartyJoseph J ShatzelPublished in: Arteriosclerosis, thrombosis, and vascular biology (2023)
URL: https://www.clinicaltrials.gov; Unique identifier: NCT04465760.